Publications Office of the EU
Open House Original Discount Contracts 2025-17 - Beclometasone, Formoterol, Glycopyrronium (combination of active ingredients) ATC: R03AL09 - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Open House Original Discount Contracts 2025-17 - Beclometasone, Formoterol, Glycopyrronium (combination of active ingredients) ATC: R03AL09 Text automatically translated in your browsing language Automatically translated

Overview
  • Published
    23/05/2025
  • Today
    22/06/2025
  • Deadline
    30/06/2027
  • Opening of tenders
    30/06/2027
Status
Published
Type of contract
Supplies
Subject for Renewal
No
Buyer
Techniker Krankenkasse
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: DE600 Hamburg
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Procedure details
Tender reference number
OH-Originale-2025-17
Description

TK pursues the objective of concluding discount agreements with all suitable pharmaceutical companies pursuant to § 130a(8) SGB V on the combination of active substances beclometasone, formoterol, glycopyrronium (ATC: R03AL09). The contract is concluded within the framework of the Open House original procedure of the TK: Individual negotiations on contract contents are not conducted, uniform conditions apply. TK does not guarantee any exclusivity to individual contractual partners. The contract period is a maximum of 24 months starting from 01.07.2025. The contract ends at the latest on 30.06.2027, regardless of the date of conclusion of the contract. In the event of patent expiration/expiration of market exclusivity before the above-mentioned end date, the contract shall automatically end at the end of the month of patent expiration/market exclusivity. It is possible to join this open-house original procedure at any time within the term of the contract. Due to the existence of industrial property rights with regard to the active substance or combination of active substances that are the subject of these proceedings, the participation and contractual documents are only made available to pharmaceutical entrepreneurs who offer/place on the market medicinal products relating to the active substance or combination of active substances that are the subject of these proceedings or make it credible to TK that they intend to offer/place on the market such medicinal products within the term of the contract. The information provided on the period of validity is not relevant in the present case and is exclusively due to the mandatory requirements of the form. All further information can be found in the participation and contract documents. Text automatically translated in your browsing language Automatically translated

Submission Method
Not available
Tenders may be submitted
Electronic submission: eu.europa.publications.PublicProcurement.electronic.submission.not-allowed
tdf-non-av
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
30/06/2027 23:59
Buyers
Handelskrankenkasse (hkk)
HEK - Hanseatische Krankenkasse
Place of performance
DE Deutschland
DE600 Hamburg
CPV code

33600000 - Pharmaceutical products

Award method
Not available
Estimated value
Not available
Final contracted value
Not available
Award of contract
Not available
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.